These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
347 related articles for article (PubMed ID: 28602548)
1. Impact of quadrivalent human papillomavirus vaccine on genital warts in an opportunistic vaccination structure. Lurie S; Mizrachi Y; Chodick G; Katz R; Schejter E Gynecol Oncol; 2017 Aug; 146(2):299-304. PubMed ID: 28602548 [TBL] [Abstract][Full Text] [Related]
2. Evaluating the Early Benefit of Quadrivalent HPV Vaccine on Genital Warts in Belgium: A Cohort Study. Dominiak-Felden G; Gobbo C; Simondon F PLoS One; 2015; 10(7):e0132404. PubMed ID: 26147096 [TBL] [Abstract][Full Text] [Related]
3. Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data. Donovan B; Franklin N; Guy R; Grulich AE; Regan DG; Ali H; Wand H; Fairley CK Lancet Infect Dis; 2011 Jan; 11(1):39-44. PubMed ID: 21067976 [TBL] [Abstract][Full Text] [Related]
4. The incidence of genital warts in Australian women prior to the national vaccination program. Brotherton JM; Heywood A; Heley S Sex Health; 2009 Sep; 6(3):178-84. PubMed ID: 19653953 [TBL] [Abstract][Full Text] [Related]
5. Trends in Male and Female Genital Warts Among Adolescents in a Safety-Net Health Care System 2004-2013: Correlation With Introduction of Female and Male Human Papillomavirus Vaccination. Perkins RB; Legler A; Hanchate A Sex Transm Dis; 2015 Dec; 42(12):665-8. PubMed ID: 26562694 [TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus vaccination and genital warts in young Indigenous Australians: national sentinel surveillance data. Ali H; McManus H; O'Connor CC; Callander D; Kong M; Graham S; Saulo D; Fairley CK; Regan DG; Grulich A; Low N; Guy RJ; Donovan B Med J Aust; 2017 Mar; 206(5):204-209. PubMed ID: 28301790 [TBL] [Abstract][Full Text] [Related]
7. Impact of the human papillomavirus (HPV) vaccine on genital wart diagnoses at Auckland Sexual Health Services. Oliphant J; Perkins N N Z Med J; 2011 Jul; 124(1339):51-8. PubMed ID: 21952330 [TBL] [Abstract][Full Text] [Related]
8. Effectiveness of HPV vaccines against genital warts in women from Valencia, Spain. Navarro-Illana E; López-Lacort M; Navarro-Illana P; Vilata JJ; Diez-Domingo J Vaccine; 2017 Jun; 35(25):3342-3346. PubMed ID: 28499554 [TBL] [Abstract][Full Text] [Related]
9. Efficacy, immunogenicity, and safety of a quadrivalent HPV vaccine in men: results of an open-label, long-term extension of a randomised, placebo-controlled, phase 3 trial. Goldstone SE; Giuliano AR; Palefsky JM; Lazcano-Ponce E; Penny ME; Cabello RE; Moreira ED; Baraldi E; Jessen H; Ferenczy A; Kurman R; Ronnett BM; Stoler MH; Bautista O; Das R; Group T; Luxembourg A; Zhou HJ; Saah A Lancet Infect Dis; 2022 Mar; 22(3):413-425. PubMed ID: 34780705 [TBL] [Abstract][Full Text] [Related]
10. Ongoing decline in genital warts among young heterosexuals 7 years after the Australian human papillomavirus (HPV) vaccination programme. Chow EP; Read TR; Wigan R; Donovan B; Chen MY; Bradshaw CS; Fairley CK Sex Transm Infect; 2015 May; 91(3):214-9. PubMed ID: 25305210 [TBL] [Abstract][Full Text] [Related]
11. [Genital warts and HPV vaccination]. Pilka R; Dvorák V; Fait T Ceska Gynekol; 2011 Dec; 76(6):468-70. PubMed ID: 22312844 [TBL] [Abstract][Full Text] [Related]
12. Early impact of Ontario's human papillomavirus (HPV) vaccination program on anogenital warts (AGWs): A population-based assessment. Guerra FM; Rosella LC; Dunn S; Wilson SE; Chen C; Deeks SL Vaccine; 2016 Sep; 34(39):4678-4683. PubMed ID: 27527815 [TBL] [Abstract][Full Text] [Related]
13. What can surveillance of genital warts tell us? Fairley CK; Donovan B Sex Health; 2010 Sep; 7(3):325-7. PubMed ID: 20719222 [TBL] [Abstract][Full Text] [Related]
14. Significant decline of HPV 6 infection and genital warts despite low HPV vaccination coverage in young women in Germany: a long-term prospective, cohort data analysis. Denecke A; Iftner T; Iftner A; Riedle S; Ocak M; Luyten A; Üye I; Tunc K; Petry KU BMC Infect Dis; 2021 Jul; 21(1):634. PubMed ID: 34215215 [TBL] [Abstract][Full Text] [Related]
15. Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data. Ali H; Donovan B; Wand H; Read TR; Regan DG; Grulich AE; Fairley CK; Guy RJ BMJ; 2013 Apr; 346():f2032. PubMed ID: 23599298 [TBL] [Abstract][Full Text] [Related]
16. The early impact of human papillomavirus vaccination on anogenital warts in Québec, Canada. Steben M; Ouhoummane N; Rodier C; Sinyavskaya L; Brassard P J Med Virol; 2018 Mar; 90(3):592-598. PubMed ID: 28980715 [TBL] [Abstract][Full Text] [Related]
17. Incidence of genital warts in adolescents and young adults in an integrated health care delivery system in the United States before human papillomavirus vaccine recommendations. Camenga DR; Dunne EF; Desai MM; Gee J; Markowitz LE; Desiliva A; Klein NP Sex Transm Dis; 2013 Jul; 40(7):534-8. PubMed ID: 23965766 [TBL] [Abstract][Full Text] [Related]
18. Association of varying number of doses of quadrivalent human papillomavirus vaccine with incidence of condyloma. Herweijer E; Leval A; Ploner A; Eloranta S; Simard JF; Dillner J; Netterlid E; Sparén P; Arnheim-Dahlström L JAMA; 2014 Feb; 311(6):597-603. PubMed ID: 24519299 [TBL] [Abstract][Full Text] [Related]
19. Substantially reduced incidence of genital warts in women and men six years after HPV vaccine availability in Sweden. Herweijer E; Ploner A; Sparén P Vaccine; 2018 Apr; 36(15):1917-1920. PubMed ID: 29523448 [TBL] [Abstract][Full Text] [Related]
20. Impact of the quadrivalent HPV vaccine on disease recurrence in men exposed to HPV Infection: a randomized study. Coskuner ER; Ozkan TA; Karakose A; Dillioglugil O; Cevik I J Sex Med; 2014 Nov; 11(11):2785-91. PubMed ID: 25124237 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]